Chai Discovery raised a $400 million Series C at a $3.8 billion valuation to scale its generative AI models for designing antibodies and proteins, building on paid discovery partnerships with Eli Lilly, Pfizer and Novartis.
A phishing attack on healthcare AI vendor Xsolis exposed sensitive data on 1.4 million patients tied to clients including Humana and Mayo Clinic Health System, with at least eight health systems confirming their patients were affected.
AI companion robot Abi, piloted in an Australian senior care home in 2025, is now coming to US facilities amid a crowded field of rivals and a $173,000 institutional robot called Moya — raising both promising acceptance rates and sharp ethical questions about cost, data, and human connection.
Germany's nationwide PRAIM program found AI-supported mammography screening lifted breast cancer detection to 6.7 per 1,000 women screened, a statistically superior 17.6% jump over standard reading, in one of the largest real-world AI screening deployments to date.
An Imperial College London study of nearly 116,000 UK mammograms found a Google AI model outperformed a radiologist's first read on sensitivity and lifted cancer detection rates from 7.54 to 9.33 per 1,000 women screened.
Medtronic won FDA clearance for a smart MDI system that merges its InPen insulin pen with Abbott's Instinct CGM sensors into one real-time dashboard, part of a broader 2026 push to ease the daily burden of diabetes management.
Humana is expanding a Google Cloud Gemini-powered tool that gives its 20,000 member advocates real-time AI assistance during calls, part of a broader 2026 push by insurers to automate customer service.
Georgia's SB 444 bars insurers from denying coverage based solely on AI, requiring human review of every algorithmic denial starting January 2027, joining a wave of state laws regulating AI in claims review.
UpDoc's FDA-cleared insulin-management chatbot marks the first patient-facing LLM authorized as a medical device, with early deployments at Cleveland Clinic, UCSF Health, and Allegheny Health Network.
Northwestern University engineers printed flexible artificial neurons from graphene and molybdenum disulfide that successfully triggered responses in living mouse brain tissue, an early step toward energy-efficient neuromorphic computing and future brain-machine interfaces.